| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d9bba82de65952cc13fdda66e14ac1d5 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-12 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-12 |
| filingDate |
2010-01-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5dda6756d5f722d7e5fc49c11426cc62
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_97749c24111dc6db153c3f903fe36450 |
| publicationDate |
2010-08-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2010204479-A1 |
| titleOfInvention |
Crystalline forms of dexlansoprazole |
| abstract |
The present invention relates to novel crystalline forms of Dexlansoprazole and a process for the preparation of amorphous Dexlansoprazole. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10370359-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8318943-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011028728-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8314241-B2 |
| priorityDate |
2009-02-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |